Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
Clinical trial NCT04681677 · TERMINATED
Trial details
- NCT number
- NCT04681677
- Sponsor
- Xoft, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2024-04-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.